Literature DB >> 10082880

Transmission routes of HIV-1 gp120 from brain to lymphoid tissues.

M F Cashion1, W A Banks, K L Bost, A J Kastin.   

Abstract

The blood-brain barrier (BBB) restricts the entry of antiviral agents into the CNS thereby facilitating the creation of a reservoir of HIV that could potentially reinfect peripheral tissues. We characterized the efflux from brain of radioactively labeled viral coat HIV-1 gp120 (I-gp120) after intracerebroventricular (i.c.v.) injection. The half-time disappearance rate of I-gp120 from brain was 12.6 min, which was faster than could be explained by the reabsorption of cerebrospinal fluid into blood but could not be explained by a saturable transporter. After i.c.v. injection, I-gp120 appeared in the serum and was sequestered by spleen and the cervical nodes, demonstrating a potential for virus within the CNS to reinfect peripheral tissues. However, the amount of I-gp120 appearing in serum was less than that expected based on the efflux rate, whereas uptake by the cervical nodes was much greater after i. c.v. than after i.v. injection of I-gp120. These findings were explained by drainage from the brain directly to the cervical lymph nodes through the brain's primitive lymphatic system. These lymphatics potentially provide a pathway through which CNS reservoirs of HIV-1 could directly reinfect lymphoid tissue without being exposed to circulating antiviral agents. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10082880     DOI: 10.1016/s0006-8993(99)01069-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

1.  Role of microglial cells in selective replication of simian immunodeficiency virus genotypes in the brain.

Authors:  Tahar Babas; Daniel Muñoz; Joseph L Mankowski; Patrick M Tarwater; Janice E Clements; M Christine Zink
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

2.  Second assessment of NeuroAIDS in Africa.

Authors:  Kevin Robertson; Kathy Kopnisky; James Hakim; Concepta Merry; Noeline Nakasujja; Colin Hall; Moussa Traore; Ned Sacktor; David Clifford; Charles Newton; Annelies Van Rie; Penny Holding; Janice Clements; Christine Zink; Jens Mielk; Mina Hosseinipour; Umesh Lalloo; Farida AMod; Christina Marra; Scott Evans; Jeff Liner
Journal:  J Neurovirol       Date:  2008-04       Impact factor: 2.643

3.  CNS-expressed cathepsin D prevents lymphopenia in a murine model of congenital neuronal ceroid lipofuscinosis.

Authors:  Zinayida Shevtsova; Manuel Garrido; Jochen Weishaupt; Paul Saftig; Mathias Bähr; Fred Lühder; Sebastian Kügler
Journal:  Am J Pathol       Date:  2010-05-20       Impact factor: 4.307

4.  Expression of CHRFAM7A and CHRNA7 in neuronal cells and postmortem brain of HIV-infected patients: considerations for HIV-associated neurocognitive disorder.

Authors:  Félix M Ramos; Manuel Delgado-Vélez; Ángel L Ortiz; Carlos A Báez-Pagán; Orestes Quesada; José A Lasalde-Dominicci
Journal:  J Neurovirol       Date:  2015-11-13       Impact factor: 2.643

Review 5.  Neurobiology of multiple insults: HIV-1-associated brain disorders in those who use illicit drugs.

Authors:  Jeanne E Bell; Juan-Carlos Arango; Iain C Anthony
Journal:  J Neuroimmune Pharmacol       Date:  2006-05-05       Impact factor: 4.147

Review 6.  Molecular mechanisms of HIV-1 associated neurodegeneration.

Authors:  Hakan Ozdener
Journal:  J Biosci       Date:  2005-06       Impact factor: 2.795

Review 7.  Neurological manifestations of patients with COVID-19: potential routes of SARS-CoV-2 neuroinvasion from the periphery to the brain.

Authors:  Zhengqian Li; Taotao Liu; Ning Yang; Dengyang Han; Xinning Mi; Yue Li; Kaixi Liu; Alain Vuylsteke; Hongbing Xiang; Xiangyang Guo
Journal:  Front Med       Date:  2020-05-04       Impact factor: 4.592

8.  Role of anti-inflammatory compounds in human immunodeficiency virus-1 glycoprotein120-mediated brain inflammation.

Authors:  Tamima Ashraf; Wenlei Jiang; Md Tozammel Hoque; Jeffrey Henderson; Chiping Wu; Reina Bendayan
Journal:  J Neuroinflammation       Date:  2014-05-16       Impact factor: 8.322

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.